Scarica l'app Stockscreener
36.71
1.09%
0.395
Dopo l'orario di chiusura:
36.71
Precedente Chiudi:
$36.31
Aprire:
$37.61
Volume 24 ore:
757.30K
Relative Volume:
0.84
Capitalizzazione di mercato:
$1.98B
Reddito:
-
Utile/perdita netta:
$-119.95M
Rapporto P/E:
-18.24
EPS:
-2.0123
Flusso di cassa netto:
$-95.28M
1 W Prestazione:
-3.52%
1M Prestazione:
+6.41%
6M Prestazione:
+192.74%
1 anno Prestazione:
+256.06%
Intervallo 1D:
$36.68
$38.27
Intervallo di 1 settimana:
$34.85
$39.15
Portata 52W:
$6.42
$39.15
Tyra Biosciences Inc Stock (TYRA) Company Profile
Nome
Tyra Biosciences Inc
Settore
Industria
Telefono
(619) 728-4760
Indirizzo
2656 STATE STREET, CARLSBAD
Compare TYRA vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
36.71 | 1.96B | 0 | -119.95M | -95.28M | -2.0123 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2026-02-10 | Iniziato | William Blair | Outperform |
| 2026-01-28 | Iniziato | Barclays | Overweight |
| 2025-09-03 | Iniziato | Raymond James | Strong Buy |
| 2025-05-21 | Ripresa | Piper Sandler | Overweight |
| 2025-01-07 | Iniziato | UBS | Buy |
| 2024-10-18 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-08-15 | Iniziato | Piper Sandler | Overweight |
| 2023-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-06-30 | Iniziato | Wedbush | Outperform |
| 2023-02-03 | Iniziato | Oppenheimer | Outperform |
| 2022-06-23 | Iniziato | H.C. Wainwright | Buy |
| 2022-03-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-11-08 | Downgrade | Jefferies | Buy → Hold |
| 2021-10-11 | Iniziato | BofA Securities | Buy |
| 2021-10-11 | Iniziato | Cowen | Outperform |
| 2021-10-11 | Iniziato | Jefferies | Buy |
Mostra tutto
Tyra Biosciences Inc Borsa (TYRA) Ultime notizie
[144] Tyra Biosciences, Inc. SEC Filing - Stock Titan
Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | CG Oncology, Janssen, Tyra Biosciences, UroGen Pharma - Barchart.com
Non Muscle Invasive Bladder Cancer Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com
Highs Report: Is Tyra Biosciences Inc forming a breakout patternChart Signals & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Dabo gratinib designation honors key Tyra Biosciences executives - Traders Union
Tyra Biosciences (NASDAQ:TYRA) Trading Down 4.5%Should You Sell? - MarketBeat
Assessing Tyra Biosciences (TYRA) Valuation After Strong One Year Share Price Performance - Sahm
Best Growth Stocks To Follow Today – March 20th - Defense World
Piper Sandler Increases Tyra Biosciences (NASDAQ:TYRA) Price Target to $56.00 - Defense World
Technical Reactions to TYRA Trends in Macro Strategies - Stock Traders Daily
Boone Capital Backs Tyra Biosciences As FGFR3 Trials Shape Outlook - Sahm
This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position - AOL.com
Boone Capital Invests in Tyra Biosciences: $10.48M Stake AcquiredNews and Statistics - IndexBox
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 - The Motley Fool
Piper Sandler Issues Positive Forecast for Tyra Biosciences (NASDAQ:TYRA) Stock Price - MarketBeat
Piper Sandler Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $56 - 富途牛牛
Tyra Biosciences (TYRA) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Forecast Cut: Can Tyra Biosciences Inc continue delivering strong returnsIPO Watch & Smart Swing Trading Techniques - baoquankhu1.vn
Hedge Fund Bets: Is Tyra Biosciences Inc a strong candidate for buy and holdQuarterly Portfolio Report & Smart Allocation Stock Tips - baoquankhu1.vn
Wedbush maintains Tyra Biosciences (TYRA) outperform recommendation - MSN
Cantor Fitzgerald initiates coverage of Tyra Biosciences (TYRA) with overweight recommendation - MSN
Tyra Biosciences (TYRA) CFO adds 1,376 shares via employee stock plan - Stock Titan
Tyra Biosciences (TYRA) CEO adds 1,463 ESPP shares, holdings reach 1.36M - Stock Titan
Ideas Watch: Is Tyra Biosciences Incs ROE strong enoughMarket Trend Report & Smart Money Movement Tracker - baoquankhu1.vn
Tyra Biosciences, Inc. $TYRA Shares Acquired by HighVista Strategies LLC - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Reaches New 1-Year HighTime to Buy? - MarketBeat
Boothbay Fund Management LLC Makes New $2.61 Million Investment in Tyra Biosciences, Inc. $TYRA - MarketBeat
Analyst Calls: What are the risks of holding Tyra Biosciences Inc2026 Price Momentum & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Tech Rally: How does MASK correlate with Nasdaq2026 Closing Moves & Community Trade Idea Sharing - baoquankhu1.vn
Tyra Biosciences, Inc. $TYRA Shares Purchased by Commodore Capital LP - MarketBeat
Tyra Biosciences deepens industry engagement at EAU26 meeting - Traders Union
Tyra Biosciences stock hits all-time high at 36.69 USD By Investing.com - Investing.com India
Tyra Biosciences stock hits all-time high at 36.69 USD - Investing.com Nigeria
ACMG meeting attendance advances FGFR3 inhibition work, Tyra Biosciences outlines - Traders Union
Director sells three 8,000‑share blocks — TYRA (NASDAQ: TYRA) - Stock Titan
Tyra Biosciences (NASDAQ:TYRA) Sets New 12-Month HighHere's What Happened - MarketBeat
Growth Stocks To Consider – March 9th - Defense World
Trading the Move, Not the Narrative: (TYRA) Edition - Stock Traders Daily
Assessing Tyra Biosciences (TYRA) Valuation After Wider Full Year Loss And Earnings Update - Sahm
TD Cowen Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating - 富途牛牛
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Aug Technicals: Is Tyra Biosciences Incs ROE strong enoughQuarterly Earnings Summary & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Update Recap: Is Tyra Biosciences Inc a strong candidate for buy and holdJuly 2025 Macro Moves & Free Community Consensus Stock Picks - baoquankhu1.vn
Assessing Tyra Biosciences (TYRA) Valuation After William Blair Coverage And Dabogratinib Progress - Sahm
Is Tyra Biosciences Inc stock undervalued right nowJuly 2025 Closing Moves & Growth Focused Stock Reports - baoquankhu1.vn
RA Capital discloses 21.2% Tyra Biosciences (TYRA) stake after dilution - Stock Titan
Tyra Biosciences stock reaches all-time high at 35.75 USD By Investing.com - Investing.com Australia
HC Wainwright Issues Optimistic Forecast for TYRA Earnings - Defense World
Tyra Biosciences stock reaches all-time high at 35.75 USD - Investing.com Nigeria
HC Wainwright Boosts Earnings Estimates for Tyra Biosciences - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year HighHere's Why - MarketBeat
Tyra Biosciences Inc Azioni (TYRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):